Pancreatic Cancer Research

ResearcherUniversity of PaduaActive in the last 2 years

Lucia Biasutto

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-7638-6865; OpenAlex author ID A5053578537. Sources: OpenAlex.

Their work

Papers
4 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
0
Collaborators
13
Papers, trials and grants by year

2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: 1 paper · 2022: none · 2023: 1 paper · 2024: none · 2025: none · 2026: 1 paper

Papers 4

  1. Tumor-specific targeting of a mitochondrial Kv1.3 channel inhibitor through conjugation to gastrin/cholecystokinin B receptor ligand strongly reduces pancreati… Co-author DOI 10.1016/j.phrs.2026.108150↗
  2. DA7R: A 7-Letter Zip Code to Target PDAC. Last author DOI 10.3390/pharmaceutics15051508↗
  3. Targeting Pancreatic Ductal Adenocarcinoma (PDAC). Last author DOI 10.33594/000000326↗
  4. Tumor-reducing effect of the clinically used drug clofazimine in a SCID mouse model of pancreatic ductal adenocarcinoma. Co-author DOI 10.18632/oncotarget.11299↗

Closest collaborators

The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Ildikò Szabó · 4 shared papers, 2017–2026 · strength 0.67
  2. Sofia Parrasia · 3 shared papers, 2021–2026 · strength 0.61
  3. Erich Gulbins · 1 shared paper, 2026 · strength 0.23
  4. Vincenzo Corbo · 1 shared paper, 2026 · strength 0.23
  5. Alessandro Carrer · 1 shared paper, 2026 · strength 0.23
  6. Elena Fiorini · 1 shared paper, 2026 · strength 0.23
  7. Carlotta Paoli · 1 shared paper, 2026 · strength 0.23
  8. Karen Legler · 1 shared paper, 2017 · strength 0.06
  9. Roberta Peruzzo · 1 shared paper, 2017 · strength 0.06
  10. Luigi Leanza · 1 shared paper, 2017 · strength 0.06
  11. Anna Trauzold · 1 shared paper, 2017 · strength 0.06
  12. Angela Zaccagnino · 1 shared paper, 2017 · strength 0.06
  13. Holger Kalthoff · 1 shared paper, 2017 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.